CDT Equity Inc. SEC Filing Summary

On December 8, 2025, CDT Equity Inc. entered into a Sale and Purchase Agreement with Corvus Capital Limited. Pursuant to this agreement, CDT Equity Inc. issued 224,800 shares of common stock and pre-funded warrants to purchase up to 3,685,815 shares of common stock to Corvus Capital Limited. This transaction was part of the acquisition of Conduit Pharmaceuticals Limited and its associated liabilities. The shares of common stock issued to Corvus are held of record by Corvus Capital Limited. Additionally, shares held by Manoira Corporation and Algo Holdings, Inc. are also noted, with Corvus Capital Limited holding a significant equity interest in Manoira and Algo Holdings, Inc. being a subsidiary of Corvus Capital Limited. Dr. Andrew Regan, CEO of Corvus Capital Limited, may be deemed to beneficially own these shares due to his relationships with these entities, though beneficial ownership is disclaimed except to the extent of pecuniary interest. The acquisition price for the common stock was $1.79 per share, and the pre-funded warrants were issued at $0.0001 per share.